Prevention of Pneumocystis carinii pneumonia with cotrimoxazole 18 mg/kg.
Postma
A
A
Kamps
W A
WA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000276:immunology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000276:immunology*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage* / Q000009:adverse effects
D015662:Trimethoprim, Sulfamethoxazole Drug Combination